Literature DB >> 1555609

Medical treatment of peripheral vascular disease: good or bad?

D Duprez, D L Clement.   

Abstract

The majority of patients with intermittent claudication are treated conservatively; smoking must be stopped and exercise therapy commenced. There are various classes of drugs that are widely prescribed for the treatment of peripheral vascular disease. In this editorial the medical treatment of peripheral vascular disease is claimed to achieve at least one of three goals: (1) improvement of the functional capability; (2) inhibition of the progression of the atherosclerotic and anatomical lesions; (3) reduction of the cardiac and cerebrovascular morbidity and mortality. Guidelines are given for well controlled trials for newly developed drugs for the treatment of peripheral vascular disease in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555609     DOI: 10.1093/oxfordjournals.eurheartj.a060138

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  2 in total

1.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

2.  Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

Authors:  N S Cook; I D Chapman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.